Gender-Specific Prognostic Impact of Treosulfan Levels in High-Dose Chemotherapy for Multiple Myeloma.

Autor: Heini AD; Department of Medical Oncology, University Hospital Inselspital and University of Bern, 3010 Bern, Switzerland., Kammermann K; Department of Medical Oncology, University Hospital Inselspital and University of Bern, 3010 Bern, Switzerland., Bacher U; Department of Hematology and Central Hematology Laboratory, University Hospital Inselspital and University of Bern, 3010 Bern, Switzerland., Jeker B; Department of Medical Oncology, University Hospital Inselspital and University of Bern, 3010 Bern, Switzerland., Hayoz M; Center of Laboratory Medicine (ZLM), University Hospital Inselspital and University of Bern, 3010 Bern, Switzerland.; Department of Clinical Chemistry, University Hospital Inselspital and University of Bern, 3010 Bern, Switzerland., Aebi Y; Center of Laboratory Medicine (ZLM), University Hospital Inselspital and University of Bern, 3010 Bern, Switzerland.; Department of Clinical Chemistry, University Hospital Inselspital and University of Bern, 3010 Bern, Switzerland., Largiadèr CR; Center of Laboratory Medicine (ZLM), University Hospital Inselspital and University of Bern, 3010 Bern, Switzerland.; Department of Clinical Chemistry, University Hospital Inselspital and University of Bern, 3010 Bern, Switzerland., Nilius H; Center of Laboratory Medicine (ZLM), University Hospital Inselspital and University of Bern, 3010 Bern, Switzerland.; Department of Clinical Chemistry, University Hospital Inselspital and University of Bern, 3010 Bern, Switzerland.; Graduate School for Health Sciences, University of Bern, 3012 Bern, Switzerland., Pabst T; Department of Medical Oncology, University Hospital Inselspital and University of Bern, 3010 Bern, Switzerland.

Publikováno v: Cancers [Cancers (Basel)] 2024 Oct 01; Vol. 16 (19). Date of Electronic Publication: 2024 Oct 01.

Peeling Back the Layers: Recurrent Talquetamab Skin Toxicity after Supportive Stem Cell Boost in Multiple Myeloma.

Autor: Heini AD; Department of Medical Oncology, Inselspital, Bern University Hospital, Bern, Switzerland, alex@heini.be., Bacher VU; Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, Bern, Switzerland., Akhoundova D; Department of Medical Oncology, Inselspital, Bern University Hospital, Bern, Switzerland., Seipel K; Department for Biomedical Research, University of Bern, Bern, Switzerland., Pabst T; Department of Medical Oncology, Inselspital, Bern University Hospital, Bern, Switzerland.

Publikováno v: Acta haematologica [Acta Haematol] 2024; Vol. 147 (6), pp. 729-734. Date of Electronic Publication: 2024 Mar 06.

Experiences with Glofitamab Administration following CAR T Therapy in Patients with Relapsed Mantle Cell Lymphoma.

Autor: Heini AD; Department of Medical Oncology, Inselspital, Bern University Hospital, 3010 Bern, Switzerland., Bacher U; Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, 3010 Bern, Switzerland., Porret N; Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, 3010 Bern, Switzerland., Wiedemann G; Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, 3010 Bern, Switzerland., Legros M; Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, 3010 Bern, Switzerland., Stalder Zeerleder D; Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, 3010 Bern, Switzerland., Seipel K; Department of Medical Oncology, Inselspital, Bern University Hospital, 3010 Bern, Switzerland., Novak U; Department of Medical Oncology, Inselspital, Bern University Hospital, 3010 Bern, Switzerland., Daskalakis M; Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, 3010 Bern, Switzerland., Pabst T; Department of Medical Oncology, Inselspital, Bern University Hospital, 3010 Bern, Switzerland.

Publikováno v: Cells [Cells] 2022 Sep 02; Vol. 11 (17). Date of Electronic Publication: 2022 Sep 02.

Clonal Hematopoiesis after Autologous Stem Cell Transplantation Does Not Confer Adverse Prognosis in Patients with AML.

Autor: Heini AD; Department of Medical Oncology, University Hospital and University of Bern, Center for Hemato-Oncology, University Cancer Center, 3010 Berne, Switzerland., Porret N; Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, 3010 Berne, Switzerland., Zenhaeusern R; Department of Medical Oncology, Spitalzentrum Oberwallis, 3900 Brig, Switzerland., Winkler A; Regionalspital Biel, 2501 Biel, Switzerland., Bacher U; Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, 3010 Berne, Switzerland., Pabst T; Department of Medical Oncology, University Hospital and University of Bern, Center for Hemato-Oncology, University Cancer Center, 3010 Berne, Switzerland.

Publikováno v: Cancers [Cancers (Basel)] 2021 Jun 25; Vol. 13 (13). Date of Electronic Publication: 2021 Jun 25.

Increased fibrinogen levels at diagnosis are associated with adverse outcome in patients with acute myeloid leukemia.

Autor: Berger MD; Department of Medical Oncology, University Hospital and University of Berne, Berne, Switzerland., Heini AD; Department of Medical Oncology, University Hospital and University of Berne, Berne, Switzerland., Seipel K; Department of Clinical Research, University Hospital and University of Berne, Berne, Switzerland., Mueller B; Department of Clinical Research, University Hospital and University of Berne, Berne, Switzerland., Angelillo-Scherrer A; Department of Hematology, University Hospital and University of Berne, Berne, Switzerland., Pabst T; Department of Medical Oncology, University Hospital and University of Berne, Berne, Switzerland.

Publikováno v: Hematological oncology [Hematol Oncol] 2017 Dec; Vol. 35 (4), pp. 789-796. Date of Electronic Publication: 2016 Jun 15.